TIRmed Pharma AB (559149-0213) was founded in 2018 by a research team together with SU Holding AB.

The development project is based on many years of basic research at, among other institutions, Stockholm University. The project has received external funds from SWElife / VINNOVA.

The company has a business model that aims to develop the TIRmed product to a stage where a partnership with or licensure to a global player in the industry can be established. This will ensure availability of resources and infrastructure that are necessary to launch the product in a global market.

Please contact Anna-Lena Spetz, CEO for more information about the company and our business.

Email: [email protected]

Phone: +46 (0) 70 747 1303

Address: Alviksvägen 1, 16753 Bromma, Sweden